Online ISSN: 3007-0244,
Print ISSN:  2410-4280
MORTALITY FROM CARDIOVASCULAR DISEASES IN THE POPULATION OF KAZAKHSTAN EXPOSED TO RADIATION
This paper reports an analysis of theSemipalatinsk historical cohort exposed to radioactive fallout from nuclear testing inthe vicinity of the Semipalatinsk nuclear test site, Kazakhstan. The cohort study, which includes 19,545 persons of exposed and comparison villages in theSemipalatinsk region, had been set up in the 1960s and comprises 582,656 personyearsof follow-up between 1960 and 1999. Radiation dose estimates in thiscohort range from 0 to 630 mGy (whole body external). Overall, the exposedpopulation showed a high mortality from cardiovascular disease. A dose-response relationship that was foundwhen analyzing the entire cohort could completely be explained by differencesbetween the baseline rates in exposed and unexposed groups. When taking thisdifference into account no statistically significant dose-response relationship for allcardiovascular disease was found.
B. Grosche1, D. Lackland2, C. Land3, S. Simon4, K. Apsalikov5, L. Pivina6 1 Federal Office for Radiation Protection, Germany; 2 Medical University of South Carolina, USA; 3 National Institutes of Health, USA; 5 Scientific Research Institute for Radiation Medicine and Ecology, Kazakhstan; 6 Semey State Medical University, Kazakhstan
1. Swerdlow AJ, Higgins CD, Smith P, Cunningham D, Hancock BW, Horwich A,et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: acollaborative British cohort study. J Natl Cancer Inst2007;99(3):206-14. 2. McGale P, Darby SC. Commentary: A dose-response relationship for radiation-induced heart disease--current issues and fu-ture prospects. Int J Epidemiol2008;37(3):518-23. 3. Roychoudhuri R, Robinson D, Putcha V, Cuzick J, Darby S, Moller H. Increased cardiovascular mortality more than fifteen years after radiotherapy forbreast cancer: a population-based study.BMC Cancer 2007;7:9. 4. Carr ZA, Land CE, Kleinerman RA, Weinstock RW, Stovall M, Griem ML, et al.Coronary heart disease after radiotherapy for peptic ulcer disease. Int J RadiatOncolBi-olPhys2005;61(3):842-50. 5. Preston DL, Shimizu Y, Pierce DA, Suyama A, Ma-buchi K. Studies of mortalityof atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality:1950-1997. Radiat Res 2003;160(4):381-407. 6. Ivanov VK, Maksioutov MA, Chekin SY, Petrov AV, Biryukov AP, Kruglova ZG,et al. The risk of radiation-induced cerebrovascular disease in Chernobyl emergency-workers.Health Phys2006;90(3):199-207. 7. Little MP, Tawn EJ, Tzoulaki I, Wakeford R, Hilde-brandt G, Paris F, et al.Review and meta-analysis of epi-demiological associations between low/moderatedoses of ionizing radiation and circulatory disease risks, and their possiblemechanisms. Radiat Environ Biophys2010;49(2):139-53. 8. Little MP, Tawn EJ, Tzoulaki I, Wakeford R, Hilde-brandt G, Paris F, et al. Asystematic review of epidemiological associations between low and moderate dosesof ionizing radiation and late cardiovascular effects, and their possible mechanisms.Radiat Res 2008;169(1):99-109. 9. McGale P, Darby SC. Low doses of ionizing radiation and circulatory diseases: a systematic review of the published epidemiological evidence. Radiat Res2005;163(3):247-57. 10. Gilbert ES, Land CE, Simon SL. Health effects from fallout. Health Phys2002;82(5):726-35. 11. Bauer S, Gusev BI, Pivina LM, Apsalikov KN, Grosche B. Radiation exposuredue to local fallout from Soviet atmospheric nuclear weapons testing in Kazakhstan:solid cancer mortality in the Semipalatinsk historical cohort, 1960-1999. Radiat Res2005;164(4):409-19. 12. Bauer S, Gusev BI, Pivina LM, Apsalikov KN, Grosche B. Esophagus cancerand radiation exposure due to nuclear test fallout: an analysis based on the data ofthe Semipalatinsk historical cohort, 1960-1999. RadiatsBiolRadioe-col2006;46(5):611-8. 13. Grosche B. Semipalatinsk test site: introduction. Radiat Environ Biophys2002;41(1):53-5. 14. Bauer S, Grosche B, Gusev BI, Strelnikov A, Pivina LM, Kurakina NN, et al.Semipalatinsk historical cohort: Causes of death in a study group from settlementsadjacent to the Semipalatinsk nuclear test site. In: Lindholm C SS, Makar B,Baverstock K, editor. Workshop on dosimetry of the population living in the proximityof the Semipalatinsk atomic weapons test site. Helsinki: EditaOyi, 2001:62-68. 15. Winkelmann RA, Tretyakov FD, Startsev NV, Kolyado IB, Gusev BI, GroscheB, et al. Cause-of-death registers in radiation-contaminated areas of the RussianFederation and Kazakhstan. Radiat Environ Biophys2002;41(1):5-11. 16. Cockerham WC, Hinote BP, Abbott P, Haerpfer C. Health lifestyles in centralAsia: the case of Kazakhstan and Kyrgyzstan. SocSci Med 2004;59(7):1409-21. 17. Simon SL, Beck HL, Gordeev K, Bouville A, Anspaugh LR, Land CE, et al.External dose estimates for Dolon village: application of the U.S./Russian jointmethod-ology. J Radiat Res (Tokyo) 2006;47Suppl A:A143-7. 18. Gordeev K, Shinkarev S, Ilyin L, Bouville A, Hoshi M, Luckyanov N, et al.Retrospective dose assessment for the population living in areas of local fallout fromthe Semipalatinsk nuclear test site Part I: External exposure. J Radiat Res (Tokyo)2006;47Suppl A:A129-36. 19. Gordeev K, Vasilenko I, Lebedev A, Bouville A, Luckyanov N, Simon SL, et al.Fallout from nuclear tests: dosimetry in Kazakhstan. Radiat Environ Bio-phys2002;41(1):61-68. 20. Land CE, Zhumadilov Z, Gusev BI, Hartshorne MH, Wiest PW, WoodwardPW, et al. Ultrasound-detected thyroid nodule prevalence and radiation dose fromfallout. Radiat Res 2008;169(4):373-83. 21. Preston DL, Lubin JH, Pierce DA, McConney M. Ep-icure User’s Guide.Seattle, WA: HiroSoft, 1993. 22. Stepanenko VF, Hoshi M, Bailiff IK, Ivannikov AI, Toyoda S, Yamamoto M, etal. Around Semipalatinsk nuclear test site: progress of dose estimations relevant tothe consequences of nuclear tests (a summary of 3rd Dosimetry Workshop on theSemipalatinsk nuclear test site area, RIRBM, Hiroshima University, Hiroshima, 9-11of March, 2005). J Radiat Res (Tokyo) 2006;47Suppl A:A1-13. 23. Bouville A, Beck HL, Simon SL. Doses from external irradiation to MarshallIslanders from Bikini and Enewetak nuclear weapons tests. Health Phys2010;99(2):143-56. 24. Schafer DW, Gilbert ES. Some statistical implications of dose uncertainty inradiation dose-response anal-yses.Radiat Res 2006;166(1):303-12. 25. Stewart FA, Heeneman S, TePoele J, Kruse J, Rus-sell NS, Gijbels M, et al.Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE-/-mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage.Am J Pathol2006;168(2):649-58. 26. Yamada M, Wong FL, Fujiwara S, Akahoshi M, Su-zuki G. Noncancer diseaseincidence in atomic bomb survi-vors, 1958-1998. Radiat Res 2004;161(6):622-32. 27. Wong FL, Yamada M, Sasaki H, Kodama K, Hosoda Y. Effects of radiation onthe longitudinal trends of total serum cholesterol levels in the atomic bomb survivors.Radiat Res 1999;151(6):736-46. 28. Sasaki H, Wong FL, Yamada M, Kodama K. The ef-fects of aging and radiationexposure on blood pressure levels of atomic bomb survivors.J ClinEpidemiol2002;55(10):974-81. 29. Vrijheid M, Cardis E, Ashmore P, Auvinen A, Bae JM, Engels H, et al. Mortalityfrom diseases other than cancer following low doses of ionizing radiation: resultsfrom the 15-Country Study of nuclear industry workers. Int J Epi-demiol2007;36(5):1126-35. 30. Hauptmann M, Mohan AK, Doody MM, Linet MS, Mabuchi K. Mortality fromdiseases of the circulatory system in radiologic technologists in the United States.Am J Epi-demiol2003;157(3):239-48. 31. Kreuzer M, Kreisheimer M, Kandel M, Schnelzer M, Tschense A, Grosche B.Mortality from cardiovascular dis-eases in the German uranium miners cohort study,1946-1998. Radiat Environ Biophys2006;45(3):159-66. 32. Villeneuve PJ, Lane RS, Morrison HI.Coronary heart disease mortality andradon exposure in the Newfoundland fluorspar miners' cohort, 1950-2001.RadiatEnviron Bio-phys2007;46(3):291-6. 33. Lackland DT, Bachman DL, Carter TD, Barker DL, Timms S, Kohli H. Thegeographic variation in stroke inci-dence in two areas of the southeastern stroke belt:the An-derson and Pee Dee Stroke Study. Stroke 1998;29(10):2061-8. 34. MininoAM, Heron MP, Murphy SL, Kochanek KD. Deaths: final data for 2004.Natl Vital Stat Rep 2007;55(19):1-119. 35. CDC, NCHS. CDC WONDER On-line Database: Centers for Disease Controland Prevention National Center for Health Statistics, 2000. 36. Lackland DT, Egan BM, Jones PJ. Impact of nativity and race on "Stroke Belt"mortality.Hypertension 1999;34(1):57-62. 37. Barker DJ, Lackland DT. Prenatal influences on stroke mortality in Englandand Wales. Stroke 2003;34(7):1598-602. 38. Howard VJ, Woolson RF, Egan BM, Nicholas JS, Adams RJ, Howard G, et al.Prevalence of hypertension by duration and age at exposure to the stroke belt. J AmSo-cHypertens2010;4(1):32-41. 39. Schultz-Hector S, Trott K-R. Radiation-induced car-diovascular diseases: is theepidemiologic evidence compatible with the radiobiologic data? Int J RadiatOncolBi-olPhys2007;67(1):10-18. 40. Girinsky T. [Effects of ionizing radiation on the blood vessel wall]. J Mal Vasc2000;25(5):321-24. French. 41. Hoel DG. Ionizing radiation and cardiovascular dis-ease.Ann N Y AcadSci2006;1076:309-17. 42. Little MP, Gola A, Tzoulaki I. A model of cardiovas-cular disease giving aplausible mechanism for the effect of fractionated low-dose ionizing radiationexpo-sure.PLoSComputBiol2009;5(10):e1000539. 43. Becker CM, Urzhumova DS. Mortality recovery and stabilization in Kazakhstan,1995-2001.Econ Hum Bi-ol2005;3(1):97-122. 44. Shimizu Y, Kodama K, Nishi N, Kasagi F, Suyama A, Soda M, et al. Radiationexposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivordata, 1950-2003. BMJ 2010;340:b5349.
Көрген адамдардың саны: 160

Түйенді сөздер:

Мақалалар санаты:

Библиографиялық сілтемелер


Авторизируйтесь для отправки комментариев